
Check out Investor Copilot custom GPT, which lets you enjoy ChatGPT functionality with recent financial information
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
[OGN] Organon & Co. Statements
Data updated 2023-Sep-24 (Sunday)Note: Easy to read financial statements for Organon & Co. [NYSE:OGN] with charts that analyze trends of statement items & metrics and compare them with peers
Share
View Financial Statements & visualize data for other stocks
Choose statement type
Choose statement frequency
Quarterly Income Statement values for Organon & Co. are rounded to enhance readability. Hover on cells below for additional contextual info. Key metrics are also provided for your convenience
2022-Mar | 2022-Jun | 2022-Sep | 2022-Dec | 2023-Mar | 2023-Jun | |
---|---|---|---|---|---|---|
Revenue Detail | 1.57 B | 1.59 B | 1.54 B | 1.49 B | 1.54 B | 1.61 B |
Cost of Revenue Detail | 561 M | 588 M | 551 M | 580 M | 580 M | 640 M |
Gross Profit Detail | 1.01 B | 997 M | 986 M | 905 M | 958 M | 968 M |
Gross Profit Margin Detail | 64.2% | 62.9% | 64.2% | 60.9% | 62.3% | 60.2% |
Total Operating Expenses Detail | 467 M | 529 M | 567 M | 568 M | 564 M | 579 M |
Operating Income Detail | 539 M | 468 M | 419 M | 337 M | 394 M | 389 M |
Operating Margin Detail | 34.4% | 29.5% | 27.3% | 22.7% | 25.6% | 24.2% |
Non-Operating Detail | - | - | - | - | - | - |
EBIT Detail | 539 M | 468 M | 419 M | 337 M | 394 M | 389 M |
EBIT Margin Detail | 34.4% | 29.5% | 27.3% | 22.7% | 25.6% | 24.2% |
Interest Detail | -97 M | -181 M | -137 M | -226 M | -159 M | -135 M |
EBT Detail | 442 M | 287 M | 282 M | 111 M | 235 M | 254 M |
Pretax Margin Detail | 28.2% | 18.1% | 18.4% | 7.5% | 15.3% | 15.8% |
Interest Coverage Ratio Detail | 5.56 | 2.59 | 3.06 | 1.49 | 2.48 | 2.88 |
Taxes Detail | 94 M | 53 M | 55 M | 3 M | 58 M | 12 M |
Minority Interest Detail | - | - | - | - | - | - |
Net Income Detail | 348 M | 234 M | 227 M | 108 M | 177 M | 242 M |
Net Margin Detail | 22.2% | 14.8% | 14.8% | 7.3% | 11.5% | 15.1% |
Related | ||||||
Depreciation & Amortization Detail | 53 M | 50 M | 57 M | 52 M | 57 M | 58 M |
EBITDA Detail | 592 M | 518 M | 476 M | 389 M | 451 M | 447 M |
EBITDA Margin Detail | 37.8% | 32.7% | 31.0% | 26.2% | 29.3% | 27.8% |
Shares Detail | 254 M | 254 M | 254 M | 254 M | 254 M | 255 M |
Diluted Shares Detail | 255 M | 255 M | 255 M | 255 M | 256 M | 256 M |
EPS Detail | 1.36 | 0.92 | 0.89 | 0.42 | 0.69 | 0.95 |
Diluted EPS Detail | 1.36 | 0.92 | 0.89 | 0.42 | 0.69 | 0.95 |
EBITDA / Share Detail | 2.32 | 2.03 | 1.87 | 1.53 | 1.76 | 1.75 |
Chart shows absolute values of Revenue using quarterly statements for Organon & Co.. Fiscal Dates standardized to enable peer comparisons
Select Income Statement line/metric for chart. Other fields & statement line items available when different statement type selected
Subsequent stock performance post quarterly earnings date till next announcement for Organon & Co.. Dates correspond to earnings announcement dates for the period when new financial data became available to the market
Related to Organon & Co.
Information for Organon & Co.
Current Detail : Recent daily/monthly performance & benchmark comparison
Historical Detail : Historical performance & related information using Time Machine
Financial Statements : Analyze Income Statement, Balance Sheet & Cashflow Statement and also compare with peers Currently Viewing
Bayesian Statement Classifier : Investigate historical financial statements to make probabalistic predictions using Artificial Intelligence
Anomaly Detection : Investigate unusual recent performance & technicals with historical context using AI
Historical Seasonality : Seasonal performance by calendar months
Dividend History : History of Dividend Yield
Technical History : Popular Technical indicator trends (RSI, MACD etc.)
Metric Deciles : Contextualizing recent performance & technical levels into historical decile buckets
Dollar Cost Averaging : Dollar Cost Average (DCA) over time in your portfolio
Moving Averages : Key Simple & Exponential Moving Averages
Historical Analogues : Insights from closest historical matches to recent performance using Artificial Intelligence
Chart Pattern Matching : Insights from similar historical charts to recent chart using Artificial Intelligence
News Stories : News stories on 2025-May-02 on Google
SEC Reports : Quarterly reports around 2025-May-02 on SEC Edgar
Compare Organon & Co. with other assets
Market Performance : Recent performance across covered assets
Historical Performance : Prior & Subsequent performance across assets on a historical date
Market Technicals : Technical indicator levels across covered assets
Market Seasonality : Seasonal performance by calendar months across covered assets
Pair Correlations : Performance Correlations with other assets
Beta : Volatility relative to the broad market
Performance Comparison : Visually compare/benchmark performance with other assets over time
Side-by-Side Comparison : Contrast with other assets over time in a side-by-side presentation
Sector : Health Care sector performance which includes Organon & Co.
Industry : Pharmaceuticals industry performance which includes Organon & Co.